Page 3 of 4 · 87 questions tagged acetate-content.
Conditions: CPC · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
Numbers first: JEEP · orforglipron. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Numbers first: WWB · dulaglutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
What I have: JEEP · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Conditions: Homopeptide · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Numbers first: SWB · orforglipron. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. This should be a straightforward calculation and I keep getting two different…
Stated plainly: FGP · mazdutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do not…
The case in front of me: HJ · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Details up front: KP · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
The particulars: 15 mg · semaglutide. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator…
Details up front: 30 mg · dulaglutide. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would…
The specifics, since they change the answer: 15 mg · ecnoglutide. I would rather understand the derivation than memorise the outcome. Two people I asked gave two…
The particulars: 50 mg · survodutide. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor…
Details up front: 30 mg · retatrutide. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is…
What I have: 2 mg · dulaglutide. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is what…
What I have: 30 mg · orforglipron. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather…
I am comparing a supplier certificate against an independent result on the same lot. The figures are clear enough; the question is what they mean and what they do…
Setup, so nobody has to ask: ERP · cagrilintide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Details up front: WWB · orforglipron. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
The method section is present, which is unusual enough that I want to make use of it. I have read the primary source rather than the summary, which has left me with…
Conditions: TFC · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
For reference: GL Biochem · semaglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
What I am working with: QSC · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full…